AC
HALO icon

AXQ Capital’s Halozyme HALO Stock Holding History

AXQ Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41M Buy
30,831
+16,277
+112% +$1.11M 0.26% 108
2026
Q1 		$941K Buy
+14,554
New +$1.03M 0.12% 253
2025
Q3 		– Sell
-7,392
Closed -$385K – 686
2025
Q2 		$385K Buy
+7,392
New +$421K 0.12% 288
2023
Q1 		– Sell
-8,531
Closed -$485K – 544
2022
Q4 		$485K Buy
+8,531
New +$437K 0.34% 99

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

AXQ Capital's HALO Position: Q2 2026 in Review

AXQ Capital increased its Halozyme (HALO) stake by 112% in Q2 2026, buying an estimated $1.11M and bringing the position to 30,831 shares worth $2.41M. The position accounts for 0.26% of the portfolio, ranked #108.

AXQ Capital first reported a position in HALO in Q4 2022 and has held it in 4 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • AXQ Capital held 30,831 shares of Halozyme worth $2.41M as of Q2 2026.
  • AXQ Capital bought 16,277 Halozyme shares in Q2 2026, an estimated $1.11M.
  • Halozyme made up 0.26% of AXQ Capital's portfolio in Q2 2026, its #108 holding.
  • AXQ Capital first reported a position in Halozyme in Q4 2022 and has held it in 4 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.